These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15576640)

  • 1. Lower doses of estrogen replacement therapy and the risk of cardiovascular disease.
    Wakatsuki A
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):e197; author reply e197. PubMed ID: 15576640
    [No Abstract]   [Full Text] [Related]  

  • 2. New information about hormone therapy and cardiovascular disease prevention in women.
    Goldie MP
    Int J Dent Hyg; 2007 Aug; 5(3):190-3. PubMed ID: 17615030
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inconveniences and risks of untreated menopause. Benefits brought by the replacement hormonal treatment].
    Drapier-Faure E
    Rev Fr Gynecol Obstet; 1992; 87(7-9):393-6. PubMed ID: 1332177
    [No Abstract]   [Full Text] [Related]  

  • 4. Do risks of hormone therapy persist after discontinuation?
    J Fam Pract; 2008 Jun; 57(6):366, 369. PubMed ID: 18677802
    [No Abstract]   [Full Text] [Related]  

  • 5. Estrogens and thrombosis.
    Schrogie JJ
    Clin Pharmacol Ther; 2008 Apr; 83(4):526. PubMed ID: 18323862
    [No Abstract]   [Full Text] [Related]  

  • 6. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
    Obstet Gynecol; 2008 Nov; 112(5):1189-92. PubMed ID: 18978127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Are hormone substitution and vitamins dangerous for elderly women with heart diseases?].
    Schenck-Gustafsson K
    Lakartidningen; 2003 May; 100(20):1784-6. PubMed ID: 12806858
    [No Abstract]   [Full Text] [Related]  

  • 9. Importance of the progestogen added to the estrogen in hormone therapy.
    Lauritzen C
    Climacteric; 2005 Dec; 8(4):398-400. PubMed ID: 16390775
    [No Abstract]   [Full Text] [Related]  

  • 10. Focus on cardiovascular health: hormone replacement therapy, estrogen replacement therapy, and selective estrogen receptor modulators.
    Walsh BW
    J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S6-8. PubMed ID: 12625632
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormone replacement therapy and risk of heart disease.
    Elliott KK
    Am Fam Physician; 1999 Nov; 60(8):2234, 2237. PubMed ID: 10593314
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.
    Wood C; Cline M
    J Natl Cancer Inst; 2008 Sep; 100(18):1335; author reply 1335-6. PubMed ID: 18780867
    [No Abstract]   [Full Text] [Related]  

  • 13. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
    Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
    Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.
    Canonico M; Olié V; Carcaillon L; Tubert-Bitter P; Scarabin PY;
    Thromb Haemost; 2008 Jan; 99(1):246-8. PubMed ID: 18217166
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
    Langer RD
    Am J Epidemiol; 2009 Mar; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of estrogen on cardiovascular disease. Prospective studies: The Framingham Study.
    Wilson PW
    Postgrad Med; 1989 Apr; Spec No():51-3; discussion 89-90. PubMed ID: 2542911
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormones and cardiovascular disease.
    Mendelsohn M
    Gynecol Endocrinol; 2008 Sep; 24(9):483-4. PubMed ID: 18958764
    [No Abstract]   [Full Text] [Related]  

  • 19. An unusual cause of recurrent chorea.
    Caviness JN; Muenter MD
    Mov Disord; 1991; 6(4):355-7. PubMed ID: 1661846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment with estrogen].
    Ingelman-Sundberg A
    Lakartidningen; 2002 Nov; 99(47):4777-8. PubMed ID: 12523062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.